Pay in 4 interest-free payments of $7.34 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Slow Gastric Emptying: It keeps food in the stomach longer, increasing the feeling of fullness and reducing overall calorie intake
Benefits: Tirzepatide: Dual-action with GLP-1 and GIP Potential for up to 22.5% weight loss Better appetite control and fat burning Supports blood sugar balance and reduces inflammation Semaglutide: Strong appetite suppression Sustainable Weight Loss (15%-20% weight loss) Helps regulate blood sugar and reduces diabetes risks Proven track record with many successful cases Which GLP-1 Weight Loss Medication is Right for You
For more information or to book your treatment, you can either email [email protected], use our online booking form or call us on 0115 882 0292.
Retatrutide is an investigational triple agonist targeting GLP-1, GIP, and glucagon receptors, currently unapproved by the MHRA, EMA, or FDA for routine clinical use
